Hologic

Investor's Business Daily

Hologic (HOLX) named ex-Stryker CEO Stephen MacMillan to the helm and put 2 Carl Icahn nominees on its board. Icahn and his affiliates have about a 12.5% stake in the medical device maker. Shares fell 0.8% to 22.12.

View Comments (0)